Coronary artery disease, a major global health concern, is effectively managed through angioplasty or bypass surgery.

Cardiologist flagged warning about a hard to treat heart disease where the plaque builds up in multiple branches of arteries.

A new study published in the British Medical Journal showed that diabetes mellitus (DM) and low BMI have negative influence ...

All implanted CTEVs remained patent through six months, demonstrated adaptive remodeling, and recellularized with host coronary artery cells – DURHAM, N.C. Humacyte, Inc. (Nasdaq: HUMA), a ...

Kochi: Aster Medcity performed robotic-assisted coronary artery bypass grafting (CABG) on a 42-year-old woman. This ensured that the patient experienc.

After coronary artery bypass grafting (CABG), evolocumab did not reduce saphenous vein graft disease rates at two years compared with placebo, according to late-breaking research presented in a Hot ...

Coronary artery bypass graft (CABG) surgery remains the gold standard treatment for patients with severe atherosclerosis, but ...

Cardiac experts emphasize heart health, preventive strategies, and treatment options on World Heart Day webinar by Kauvery ...

Heart surgeon Sudhir Srivastava saw a global need for less-invasive surgical care at an affordable price. His company, SS ...

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...

Addition of the PCSK9 inhibitor evolocumab to statin therapy after CABG surgery does not improve 24-month graft patency, in ...

After coronary artery bypass grafting (CABG), evolocumab did not reduce saphenous vein graft disease rates at 2 years compared with placebo, according to late-breaking research presented in a Hot Line ...